Raya, Pedro Mezquita
2 papers on CoChat
Most cited papers
- Verified
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 850
- Verified
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Rodbard, H. W., Rosenstock, J., Canani, L. H., Deerochanawong, C., Gumprecht, J., Lindberg, S. Ø., Lingvay, I., Søndergaard, A. L., Treppendahl, M. B., Montanya, E., et al. (2019) · Diabetes Care
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 463
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free